Regulatory strategy for filing NDA /ANDA

Abstract

In Pharmaceutical Industry, Regulatory Affairs Department makes an interface between the regulatory authorities and
pharmaceutical industry. The Regulatory Affairs department is an important part of the organizational structure of pharmaceutical
companies. Internally it liaises at the inter phase of drug development, manufacturing, marketing and clinical research. Externally
it is the key interface between the company and the regulatory authorities. Regulatory Affairs is involved in the development of
new medicinal products from early on, by integrating regulatory principles and by preparing and submitting the relevant
regulatory dossiers to health authorities. Regulatory Affairs is actively involved in every stage of development of a new medicine
and in the post-marketing activities with authorized medicinal products. This professional can play a key role in guiding drug
development strategy in an increasingly global environment and has an important role for submitting the newly discovered drug
products approval documents to the US FDA regulatory authorities and to carry out all the practices required for obtaining the
drug products approval. This article mainly focuses on the US FDA drug approval strategies. These strategies playing core job in
the pharmaceutical industry. These strategies having all the guidelines which are indispensable part of the IND, NDA and ANDA
drug approval applications. It plays a significant role in sequence for registration of newly exposed products and also providing
the guidelines which is helpful preparing the registration documents to regulatory authorities.